Figure 5.

GPA reduces cCr uptake only in WT cells and Cr‐d3 uptake in WT and patient cells. (A) Measured pcCr levels in WT and four different CTD patient fibroblasts treated with cCr in the presence or absence of 1 mmol/L GPA. (B) Measured Cr‐d3 levels in WT and CTD patient fibroblasts treated with cCr in the presence or absence of 1 mmol/L GPA. Measurements normalized to total protein